Battery Ventures Takes Enzo Biochem Private

Verdesian Life Sciences Acquires Cytozyme Laboratories

April 27, 2021

Agriculture

Verdesian Life Sciences has acquired Cytozyme Laboratories, Inc.; Cascadia Capital served as exclusive financial advisor to Cytozyme. The acquisition brings together complementary biological and nutritional crop technologies to expand Verdesian's product portfolio and support sustainable yield solutions for growers.

Battery Ventures Acquires Labguru to Join Titian Software Platform

April 17, 2024

Cloud & SaaS

Battery Ventures acquired Labguru (BioData Inc.) from Holtzbrinck Digital and will combine Labguru with its portfolio company Titian Software to create an integrated, global life-science lab- and sample-management platform. Labguru's ELN/LIMS/informatics capabilities will be folded into the Titian-led platform to expand end-to-end offerings for biotech, pharma and research institutions; terms were not disclosed.

BioMarin Acquires Inozyme Pharma

May 16, 2025

Biotechnology

BioMarin Pharmaceutical Inc. completed its acquisition of Inozyme Pharma, Inc. in an all-cash transaction valued at approximately $270 million ($4.00 per share). The deal adds Inozyme's late-stage enzyme replacement therapy INZ-701 for ENPP1 Deficiency to BioMarin's enzyme-therapy portfolio and is expected to accelerate development toward potential regulatory approval.

Retriev Technologies Acquires Battery Solutions

March 9, 2022

Environmental Services

Retriev Technologies has acquired Battery Solutions to create the largest comprehensive end-of-life battery management solution in North America. The deal combines Retriev's lithium‑ion processing capabilities with Battery Solutions' cross‑chemistry collection, sorting, logistics and fulfillment network to expand capacity and service offerings across EV, telecom, consumer electronics and waste management end markets.

Battery Ventures Acquires LI-COR Biosciences

December 8, 2021

Manufacturing

Battery Ventures, a technology-focused investment firm, has acquired LI-COR Biosciences, a Lincoln, Nebraska-based maker of analytical and environmental-monitoring instruments and life-science imaging systems. The deal will see LI-COR's CEO Greg Biggs transition to an advisory role while Battery places Thomas Reslewic as CEO and aims to grow LI-COR organically and via targeted acquisitions.

BorgWarner Invests in Enexor BioEnergy

August 23, 2021

Renewable Energy

BorgWarner made a $10 million Series A minority investment in Enexor BioEnergy to support commercialization of the startup's on-site renewable energy and carbon-conversion systems. The investment strengthens BorgWarner's sustainability and clean-energy technology portfolio and enables collaboration on low‑carbon power solutions.